[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366726-105":59,"doc-detail-366726-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","advances-in-nanotechnology-in-the-diagnosis-and-treatment-of-gynecological-cancers","Advances in Nanotechnology in the Diagnosis and Treatment of Gynecological Cancers","","Nanotechnology platforms enable therapeutic drug delivery and improve performance versus conventional anticancer drugs through advantages including biocompatibility, reduced inflammatory responses, high therapeutic output, biodegradability, non-toxicity, and overall compatibility. Because traditional delivery to cancerous tissues has inherent limitations, nanotechnology-based alternatives have expanded for gynecologic malignancies. This systematic review summarizes recent nanomaterial research for diagnosis and treatment of cervical, endometrial, and ovarian cancers, covering diagnostic and therapeutic strategies and evaluating toxicity, technology, and clinical translation challenges while supporting more precise care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/advances-in-nanotechnology-in-the-diagnosis-and-treatment-of-gynecological-cancers/366726/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/advances-in-nanotechnology-in-the-diagnosis-and-treatment-of-gynecological-cancers/366726.png","ImageObject",300,407,{"name":92,"@type":93},"Anna Hans","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which gynecologic cancers are discussed as major disease burdens?","Question",{"text":112,"@type":113},"The review highlights ovarian cancer, cervical cancer, and endometrial cancer as the three major gynecological malignancies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is nanotechnology considered important for gynecological cancer care?",{"text":117,"@type":113},"Nanotechnology addresses limitations of conventional therapies by enabling targeted drug delivery, biosensing, and thermotherapy that can reduce toxicity and improve therapeutic efficacy while helping counter metastasis and drug resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"What main challenges of nanotechnology are emphasized?",{"text":121,"@type":113},"Key challenges include toxicity concerns, technological limitations, and difficulties related to clinical translation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366726,1790198752,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nAdvances in Nanotechnology in the Diagnosis and Treatment of Gynecological Cancers  \nRuimin Zhao 1 , Zongyu Liu2 , Limei Fan 1 , Miaomiao Fu 1 , Yishi Wu 1  \n1Department of Gynecology, The Second Hospital of Jilin University, Changchun, Jilin, 130000, People’s Republic of China; 2Department of Colorectal and Anal Surgery, The Second Hospital of Jilin University, Changchun, Jilin, 130000, People’s Republic of China  \nCorrespondence: Yishi Wu, [Email wys610428@jlu.edu.cn](Email wys610428@jlu.edu.cn)  \n\n| Abstract: Nanotechnology platforms facilitate therapeutic drug delivery and offer various advantages over conventional drugs, such as biocompatibility, non-inflammatory effects, high therapeutic output, biodegradability, non-toxicity, and biocompatibility. Due to the inherent drawbacks of conventional drug delivery to cancerous tissues, nanotechnology-based alternatives have been developed for such diseases. Gynecologic malignant tumors (GCs), include various types of cervical, endometrial, and ovarian cancers. The epidemiological characteristics of the tumors show that their incidence is increasing significantly and tends to be younger, which is a serious threat to women’s physical and mental health. This article provides a systematic review of the latest research results on nanomaterials in the diagnosis and treatment of gynecological malignancies, including 2 sections on nanomaterials-based diagnostic and therapeutic strategies in gynecological cancers. In particular, the article also analyzes the challenges faced by nanotechnology, including toxicity, technology, and clinical translation issues. These applications not only improve the therapeutic efficacy of gynecological cancers, but also reduce the toxicity and side effects, and provide a new direction for the precise treatment of gynecological cancers.\u003Cbr>Keywords: gynecologic cancer, nanomaterials, diagnosis, treatment, emerging tools |\n| --- |\n| Introduction\u003Cbr>The Current Situation of Gynecological Cancer\u003Cbr>Nowadays, the three major gynecological malignancies, ovarian cancer, cervical cancer and endometrial cancer, together constitute a heavy disease burden.1–3 Ovarian cancer has the highest mortality rate among gynecologic malignancies.4 Cervical cancer is the most common malignancy in gynecology and the fourth leading cause of cancer deaths in women worldwide.5 Although the incidence of cervical cancer has declined in many regions over the past three decades, its global incidence and burden remain high.6 In addition, endometrial cancer has increased in incidence and age of onset, significantly affecting female fertility and quality of life.7\u003Cbr>Significance of Nanomaterials in Gynecological Cancer Diagnosis and Treatment For patients after tumor reduction surgery, chemotherapy with platinum-based drugs and paclitaxel is the currently recommended treatment of choice. However, the survival rate of patients with advanced gynecologic cancers is still unsatisfactory due to the problems of late diagnosis and chemotherapy resistance and tumor recurrence, invasion, and metastasis.8 Late diagnosis of advanced gynecologic cancers and limited treatment options are key factors contributing to high mortality rates, thus highlighting the need and urgency for further research and development in this area.9\u003Cbr>Nanotechnology has emerged as a promising field that offers great solutions to the limitations of conventional therapies.10 Nanomaterial-based targeted drug delivery systems, biosensors, and thermotherapy offer more options for cancer patients than conventional surgery, chemotherapy, and radiotherapy.11, 12 These technologies demonstrate significant potential in treating gynecological malignancies, enabling the reduction of toxicity, enhancement of therapeutic efficacy, suppression of cancer cell metastasis, and countering drug resistance.13–15 In recent years a variety of novel |\n\nReceived: 25 May","cbCaighLnvzFCncM","https://ap.wps.com/l/cbCaighLnvzFCncM","pdf",4228480,"English","# Introduction\n## The Current Situation of Gynecological Cancer\n## Significance of Nanomaterials in Gynecological Cancer Diagnosis and Treatment\n# Types of Nanomaterials","[{\"question\":\"Which gynecologic cancers are discussed as major disease burdens?\",\"answer\":\"The review highlights ovarian cancer, cervical cancer, and endometrial cancer as the three major gynecological malignancies.\"},{\"question\":\"Why is nanotechnology considered important for gynecological cancer care?\",\"answer\":\"Nanotechnology addresses limitations of conventional therapies by enabling targeted drug delivery, biosensing, and thermotherapy that can reduce toxicity and improve therapeutic efficacy while helping counter metastasis and drug resistance.\"},{\"question\":\"What main challenges of nanotechnology are emphasized?\",\"answer\":\"Key challenges include toxicity concerns, technological limitations, and difficulties related to clinical translation.\"}]","Advances in Nanotechnology in the Diagnosis and Treatment of Gynecological Cancers | PDF",1790166869,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f97ac2b9acbba3705bc64cd8e4b913a0.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d80a7923ab5419525471ca0e7ba7aef.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/150c04c449961402c565c78c399c4cb2.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2047ad84280abb75285533ee1cffcd89.webp",980,1268]